Related Experiment Video
Updated: Dec 25, 2025

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
Published on: September 1, 2018
pH-Dependent Grafting of Cancer Cells with Antigenic Epitopes Promotes Selective Antibody-Mediated Cytotoxicity
Janessa Wehr1, Eden L Sikorski1, Elizabeth Bloch1
1Department of Chemistry, Lehigh University, Bethlehem, Pennsylvania 18015, United States.
Abstract:
A growing class of immunotherapeutics work by redirecting components of the immune system to recognize markers on the surface of cancer cells. However, such modalities will remain confined to a relatively small subgroup of patients because of the lack of universal targetable tumor biomarkers among all patients. Here, we designed a unique class of agents that exploit the inherent acidity of solid tumors to selectively graft cancer cells with immuno-engager epitopes. Our targeting approach is based on pHLIP, a unique peptide that selectively targets tumors in vivo by anchoring to cancer cell surfaces in a pH-dependent manner. We established that pHLIP-antigen conjugates trigger the recruitment of antibodies to the surface of cancer cells and induce cytotoxicity by peripheral blood mononuclear and engineered NK cells. These results indicate that these agents have the potential to be applicable to treating a wide range of solid tumors and to circumvent problems associated with narrow windows of selectivity.
Insights
This study introduces novel immuno-engager agents that target solid tumors by exploiting tumor acidity, enabling broader cancer immunotherapy applications. These agents harness the pH-Low Insertion Peptide (pHLIP) to engage immune cells for cancer cell destruction.
Area of Science:
- Oncology
- Immunology
- Biochemistry
Background:
- Current immunotherapies face limitations due to the lack of universal cancer biomarkers.
- Targeting specific tumor markers restricts treatment to a small patient subgroup.
Purpose of the Study:
- To develop a novel class of cancer therapeutics that target solid tumors universally.
- To exploit the unique acidic tumor microenvironment for selective cancer cell targeting.
Main Methods:
- Designed immuno-engager agents utilizing the pH-Low Insertion Peptide (pHLIP) for pH-dependent tumor cell surface anchoring.
- Conjugated pHLIP with antigens to create targeted epitopes.
- Assessed the ability of pHLIP-antigen conjugates to recruit immune cells and induce cytotoxicity.
Main Results:
- pHLIP-antigen conjugates selectively grafted cancer cells in a pH-dependent manner.
- These conjugates effectively recruited antibodies to the cancer cell surface.
- Demonstrated induction of cytotoxicity by peripheral blood mononuclear cells and engineered NK cells.
Conclusions:
- The developed agents offer a promising approach for treating a wide range of solid tumors.
- This strategy circumvents limitations associated with narrow tumor biomarker selectivity.
- Exploiting tumor acidity provides a universal targeting mechanism for immunotherapy.
More Related Videos
11:55Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
Published on: March 14, 2011
13:19Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
Published on: April 26, 2024
Related Concept Videos
Cell-mediated Immune Responses
Tumor Immunotherapy
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Hybridoma Technology
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...